TickerGuard
Buy Day today: Neutral (46) Mixed market breadth · no major macro event
ALGN

Align Technology Inc

Healthcare · Medical Instruments & Supplies

149.90$ -2.5% vs. previous close Closing price · As of: Oct 30, 2026

Ownership

Ownership Structure

Who owns Align Technology Inc (ALGN)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 94.1% of the shares are freely tradable; institutional investors hold 101.7%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 101.7%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 6.8%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 94.1%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 6.8%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 71Mio.

Largest Shareholders

Institutions

Institutions ALGN
Name Stake (%) Shares Change (%) Date
BlackRock Inc 6.22 4,419,366 +3.0 06/30/2026
Vanguard Capital Management, LLC 6.20 4,401,313 +0.3 06/30/2026
FMR Inc 5.72 4,060,032 +50.4 06/30/2026
Capital Research & Mgmt Co - Division 3 5.69 4,045,561 +6.2 06/30/2026
Capital World Investors 4.82 3,422,385 -16.0 06/30/2026
The Goldman Sachs Group Inc 4.75 3,372,760 +87.8 06/30/2026
Vanguard Portfolio Management, LLC 4.41 3,131,764 -0.6 06/30/2026
State Street Corp 3.60 2,558,512 +1.7 06/30/2026
Geode Capital Management, LLC 3.16 2,245,315 +25.4 06/30/2026

Funds

Funds ALGN
Name Stake (%) Shares Change (%) Date
Fidelity Contrafund 3.52 2,499,880 +0.0 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?